Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Naproxcinod

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Naproxcinod?

Naproxcinod is an investigational drug.

There have been 9 clinical trials for Naproxcinod. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2005.

The most common disease conditions in clinical trials are Osteoarthritis, Hypertension, and Osteoarthritis, Knee. The leading clinical trial sponsors are NicOx and [disabled in preview].

Recent Clinical Trials for Naproxcinod
Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in MaleNicOxPhase 1
Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of FurosemideNicOxPhase 1
A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal FunctionNicOxPhase 1

See all Naproxcinod clinical trials

Clinical Trial Summary for Naproxcinod

Top disease conditions for Naproxcinod
Top clinical trial sponsors for Naproxcinod

See all Naproxcinod clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.